Bordeaux

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Vitiligo Treatment by Targeting TYK2 Mediated Responses	Skin and Connective Tissue Diseases, hypopigmentation of the skin, skin disorder, skin pigmentation disorder, vitiligo	Active, not recruiting	Phase 2	2026-05-20		NCT06327321

Clinical trials